Skip to main content

Table 3 BPI-SF pain scores according to BTA treatment and risk statusa

From: Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents– a real-world cross-sectional study from Switzerland (SAKK 95/16)

  Overall sample
Receiving BTA Therapy
Known risk status
Bone complication risk
No (n = 104) Yes (n = 296) High (n = 229) Low (n = 155)
BPI-SF Worst pain n (%) n (%) n (%) n (%)
No 31 (30) 81 (27) 64 (28.0) 43 (28)
Mild 53 (51) 121 (41) 97 (42.7) 71 (46)
Moderate 8 (8) 47 (16) 34 (14.5) 19 (12)
Severe 12 (11) 47 (16) 34 (14.5) 22 (14)
  1. Note: Pain assessment was missing for 17 patients;
  2. a risk of bone complications was defined by the treating physician based on estimated risk for pathological fractures, surgery or radiation to bone, or spinal cord compression